PILL:NYE-Direxion Daily Pharmaceutical & Medical Bull 3X Shares ETF (USD)

ETF | Trading--Leveraged Equity |

Last Closing

USD 5.57

Change

0.00 (0.00)%

Market Cap

N/A

Volume

0.09M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-06-15 )

Largest Industry Peers for Trading--Leveraged Equity

ETFs Containing PILL

N/A

Market Performance

  Market Performance vs. Industry/Classification (Trading--Leveraged Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -21.55% 18% F 9% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return -21.55% 18% F 8% B-
Trailing 12 Months  
Capital Gain -10.88% 30% F 18% F
Dividend Return 0.82% 55% F 17% F
Total Return -10.06% 31% F 16% F
Trailing 5 Years  
Capital Gain -62.21% 6% D- 6% D-
Dividend Return 1.90% 18% F 4% F
Total Return -60.31% 6% D- 5% F
Average Annual (5 Year Horizon)  
Capital Gain 49.64% 91% A- 95% A
Dividend Return 50.29% 93% A 95% A
Total Return 0.65% 44% F 16% F
Risk Return Profile  
Volatility (Standard Deviation) 393.10% 7% C- 3% F
Risk Adjusted Return 12.79% 31% F 33% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.